Maybe my thinking is wrong but the company would have no expenses, manufacturing, distribution or sales force . If 200mil are sold, 200mil x .25 = 50 mil on covid only. More than enough for expansion and all rapid bacteria detection sales belong to the company. OK, I'll revise to .50 or $1 per test kit. Don't think the company could get more than $1 max per kit. Looking forward to other opinions and projections.